Limited role of the Toll-like receptor-2 in resistance to Mycobacterium avium

Immunology

Volumn 111, Issue 2, 2004, Pages 179-185

  Gomes, M Salomé ^a,b   Flórido, Manuela ^a   Cordeiro, João V ^a   Teixeira, C Miguel ^a   Takeuchi, Osamu ^c   Akira, Shizuo ^c   Appelberg, Rui ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; PROTEIN P40; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE DISRUPTION; GENETIC SUSCEPTIBILITY; IMMUNITY; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-12; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MYCOBACTERIUM AVIUM; RECEPTORS, CELL SURFACE; SPLEEN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS; TUBERCULOSIS;

EID: 0842265556     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0019-2805.2003.01807.x     Document Type: Article

References (39)

1. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997; 91:295-8.
2. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2:947-50.
3. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1:135-45.
4. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388:394-7.
5. Medzhitov R, Janeway CA Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000; 173:89-97.
6. Underhill DM, Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002; 14:103-10.
7. Vasselon T, Detmers PA. Toll receptors: a central element in innate immune responses. Infect Immun 2002; 70:1033-41.
8. Jones BW, Means TK, Heldwein KA, Keen MA, Hill PJ, Belisle JT, Fenton MJ. Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol 2001; 69:1036-44.
9. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000; 97:13766-71.
10. Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001; 276:37692-9.
11. Brightbill HD, Libraty DH, Krutzik SR et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 1999; 285:732-5.
12. Means TK, Lien E, Yoshimura A, Wang S, Golenbock DT, Fenton MJ. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol 1999; 163:6748-55.
13. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163:3920-7.
14. Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle JT, Golenbock DT, Boom WH, Harding CV. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 2001; 167:910-8.
15. Lien E, Sellati TJ, Yoshimura A et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274:33419-25.
16. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999; 96:14459-14463.
17. Krutzik SR, Ochoa MT, Sieling PA et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med 2003; 9:525-31.
18. Thoma-Uszynski Stenger S, Takeuchi O, Ochoa MT et al. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 2001; 291:1544-7.
19. Wang T, Lafuse WP, Zwilling BS. Regulation of Toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J Immunol 2000; 165:6308-13.
20. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and descriminates between pathogens. Nature 1999; 401:811-5.
21. Kang TJ, Chae GT. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 2001; 31:53-8.
22. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11:443-51.
23. Werts C, Tapping RI, Mathison JC et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001; 2:346-52.
24. Takeuchi O, Hoshino K, Akira S. Cutting-edge. TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165:5392-6.
25. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, Kirschning CJ, Weis JJ. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 2002; 168:348-55.
26. Reiling N, Holscher C, Fehrenbach A, Kroger S, Kirschning CJ, Goyert S, Ehlers S. Toll-like receptor (TLR)2-and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 2002; 169:3480-4.
27. Pais TF, Cunha JF, Appelberg R. Antigen specifity of T-cell response to Mycobacterium avium infection in mice. Infect Immun 2000; 68:4805-10.
28. Gomes MS, Appelberg R. NRAMP1-or cytokine-induced bacteriostasis of Mycobacterium avium by mouse macrophages is independent of the respiratory burst. Microbiology 2002; 148:3155-60.
29. Appelberg R, Castro AG, Pedrosa J, Silva RA, Orme IM, Minóprio P. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect Immun 1994; 62:3962-71.
30. Silva RA, Pais TF, Appelberg R. Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections. J Immunol 1998; 161:5578-85.
31. Silva RA, Flórido M, Appelberg R. Interleukin-12 primes CD4+ T cells for interferon-γ production and protective immunity during Mycobacterium avium infection. Immunology 2001; 103:368-74.
32. Stenger S, Modlin RL. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr Opin Immunol 2002; 14:452-7.
33. Silva RA, Gomes MS, Appelberg R. Minor role played by type I tumour necrosis factor receptor in the control of Mycobacterium avium proliferation in infected mice. Immunology 2000; 99:203-7.
34. Sarmento AM, Appelberg R. Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor-α production in infected mice and in vitro-cultured mouse macrophages. Infect Immun 1995; 63:3759-64.
35. Tailleux L, Schwartz O, Herrmann J-L et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 2003; 197:121-7.
36. Fratazzi C, Manjunath N, Arbeit RD, Carini C, Gerken TA, Ardman B, O'Donnell ER, Remold HG. A macrophage invasion mechanism for mycobacteria implicating the extracellular domain of CD43. J Exp Med 2000; 192:183-91.
37. Bernardo J, Billingslea AM, Blumenthal RL, Seetoo KF, Simons ER, Fenton MJ. Differential responses of human mononuclear phagocytes to mycobacterial lipoarabinomannans. role of CD14 and the mannose receptor. Infect Immun 1998; 66:28-35.
38. Means TK, Jones BW, Schromm AB et al. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol 2001; 166:4074-82.
39. Abel B, Thieblemont N, Quesniaux VJF, Brown N, Mpagi J, Miyake K, Bihl F, Ryffel B. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 2002; 169:3155-62.